Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
Smoore and AIM extend inhalation-device research agreement
Smoore announced that its subsidiary Shenzhen Smoore Technology Limited entered into a two-year extension of its research agreement with AIM ImmunoTech to develop and test a new inhalation delivery device for Ampligen.
2020
AIM ImmunoTech reports 2019 year-end financial results
AIM ImmunoTech announced financial results for the fiscal year ended December 31, 2019, and provided a business update.